Lighthouse Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Lighthouse Investment Partners’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$375K	Sell	485 -280	-37%	-$214K	0.01%	562
2025 Q4	$590K	Sell	765 -2,435	-76%	-$1.65M	0.02%	570
2025 Q3	$1.8M	Hold	3,200	–	–	0.05%	352
2025 Q2	$1.68M	Buy	+3,200	New	+$1.79M	0.06%	329
2025 Q1	–	Sell	-3,300	Closed	-$2.35M	–	613
2024 Q4	$2.35M	Buy	+3,300	New	+$2.77M	0.08%	268
2024 Q3	–	Sell	-12,536	Closed	-$13.2M	–	537
2024 Q2	$13.2M	Buy	12,536 +7,348	+142%	+$7.12M	0.53%	38
2024 Q1	$4.99M	Buy	+5,188	New	+$4.93M	0.23%	131

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Lighthouse Investment Partners's REGN Position: Q1 2026 in Review

Lighthouse Investment Partners reduced its Regeneron Pharmaceuticals (REGN) stake by 37% in Q1 2026, selling an estimated $214K and leaving 485 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #562.

Lighthouse Investment Partners first reported a position in REGN in Q1 2024 and has held it in 7 quarters since. The position peaked at $13.2M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Lighthouse Investment Partners held 485 shares of Regeneron Pharmaceuticals worth $375K as of Q1 2026.
Lighthouse Investment Partners sold 280 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $214K.
Regeneron Pharmaceuticals made up 0.01% of Lighthouse Investment Partners's portfolio in Q1 2026, its #562 holding.
Lighthouse Investment Partners first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
Lighthouse Investment Partners's Regeneron Pharmaceuticals position peaked at $13.2M in Q2 2024.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.